Medical Oncology

Papers
(The median citation count of Medical Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Steps in metastasis: an updated review130
Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression66
Cancer treatment during COVID-19 pandemic52
Delta-radiomics increases multicentre reproducibility: a phantom study47
Exosomes and cancer: from molecular mechanisms to clinical applications47
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review32
Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?31
An updated review of epidemiology, risk factors, and management of male breast cancer31
Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia30
Myths and facts about artificial intelligence: why machine- and deep-learning will not replace interventional radiologists29
Artificial Intelligence in radiotherapy: state of the art and future directions29
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?28
COVID-19 and cancer care: what do international guidelines say?24
Neuroendocrine breast carcinoma: a rare but challenging entity24
Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer23
Circular RNAs and their participation in stemness of cancer23
MicroRNAs and target molecules in bladder cancer23
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors23
Extracellular vesicle isolation from human renal cancer tissue22
Associated analysis of PER1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders19
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance19
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells19
Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition19
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer19
RFA of primary and metastatic lung tumors: long-term results18
Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis18
Wee1 kinase inhibitor AZD1775 potentiates CD8+ T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation18
Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target18
Cinnamaldehyde induces endogenous apoptosis of the prostate cancer-associated fibroblasts via interfering the Glutathione-associated mitochondria function17
De novo neuroendocrine transdifferentiation in primary prostate cancer–a phenotype associated with advanced clinico-pathologic features and aggressive outcome17
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer17
Vaccination of cancer patients against COVID-19: towards the end of a dilemma16
Integration of gene expression data identifies key genes and pathways in colorectal cancer16
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer15
Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy15
PARP1-modulated chromatin remodeling is a new target for cancer treatment15
The role of inflammatory indices in the outcome of COVID-19 cancer patients14
Cancer induced bone pain: current management and future perspectives14
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status14
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer14
Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel14
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs14
Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy13
Cancer stem cell characteristics and their potential as therapeutic targets13
High KIFC1 expression is associated with poor prognosis in prostate cancer13
Organoid culture system for patient-derived lung metastatic osteosarcoma13
Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells13
Quality of life, symptoms and dietary habits in oncology outpatients with malnutrition: A cross-sectional study12
Resveratrol effects in oral cancer cells: a comprehensive review12
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer12
SBRT in non-spine bone metastases: a literature review12
Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1α-mediated glycolysis12
Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells12
Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis12
Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients12
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial12
Innovation in cancer therapeutics and regulatory perspectives12
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives12
MRI-guided vacuum-assisted breast biopsy: experience of a single tertiary referral cancer centre and prospects for the future11
Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions11
Synergistic effects of multiple myeloma cells and tumor-associated macrophages on vascular endothelial cells in vitro11
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)11
N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM811
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients11
ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions11
Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy11
Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis11
Influence of ballroom dancing on fatigue, body image, self-efficacy, and endurance of cancer patients and their partners11
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer11
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling11
Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study10
Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer10
Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancer10
Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method10
Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy10
Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma10
MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment10
Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor10
Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study10
A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer9
Transcription factor YY1 mediates epithelial–mesenchymal transition through the TGFβ signaling pathway in bladder cancer9
The prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer9
Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug9
The effect of metformin when combined with neoadjuvant chemotherapy in breast cancer patients9
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer9
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a mu9
Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumors9
The effect of itraconazole on the clinical outcomes of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a randomized controlled study9
ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma9
Trillin prevents proliferation and induces apoptosis through inhibiting STAT3 nuclear translocation in hepatoma carcinoma cells9
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer9
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine9
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials9
A closer look to the new frontier of artificial intelligence in the percutaneous treatment of primary lesions of the liver9
SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone8
The apoptotic efficacy of succinic acid on renal cancer cell lines8
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial8
Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion8
SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer8
Adoptive cell therapy of patient-derived renal cell carcinoma xenograft model with IL-15-induced γδT cells8
Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line8
The effective natural compounds for inhibiting Cervical cancer8
The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer8
The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5B8
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer8
Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention8
Novel molecules as the emerging trends in cancer treatment: an update8
Thermal Ablation versus SBRT in liver tumours: pros and cons8
Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis8
Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care8
Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy7
ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis7
Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?7
SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling7
The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era7
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells7
The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway7
Potential use of kiwifruit extract for treatment of melanoma7
Primary pulmonary lymphoepithelioma-like carcinoma7
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions7
Disease spectrum of gastric cancer susceptibility genes7
Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools7
Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis7
Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice7
Exosome application in tumorigenesis: diagnosis and treatment of melanoma7
ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis7
Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes6
The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy6
DNMT1 and miRNAs: possible epigenetics footprints in electromagnetic fields utilization in oncology6
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancer6
The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines6
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies6
Percutaneous US-guided MWA of small liver HCC: predictors of outcome and risk factors for complications from a single center experience6
CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia6
Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma6
Ablation, consolidation and radiotherapy for the management of metastatic lesions of the spine: impact on the quality of life in a mid-term clinical and diagnostic follow-up in a pilot study6
The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 si6
Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress6
Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways6
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis6
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on qual6
Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth6
Restraint stress abates the antioxidant potential of melatonin on dimethyl benz (a) anthracene (DMBA) induced carcinogenesis6
Analyzing the impact of ATF3 in tumorigenesis and immune cell infiltration of ovarian tumor: a bioinformatics study6
Ablation for hepatocellular carcinoma: beyond the standard indications6
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype6
HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse6
Identification of key genes in the tumor microenvironment of lung adenocarcinoma6
Economic perspective of cancer treatment in India6
RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer5
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention5
Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions5
ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer5
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer5
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells5
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 25
Nicaraven prevents the fast growth of inflamed tumors by an anti-inflammatory mechanism5
Providing optimal interventional oncology procedures at one of the COVID-19 referral center in Italy5
Sarcoid-like reaction in cases treated by checkpoint inhibitors5
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance5
β-Arrestin inhibition induces autophagy, apoptosis, G0/G1 cell cycle arrest in agonist-activated V2R receptor in breast cancer cells5
B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer5
Follow-up of percutaneous microwave (MW) ablation of hepatic lesion: predictive value of CT at 24-h compared with CT at 1 month5
HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis5
Biological activity and molecular docking studies of some new quinolines as potent anticancer agents5
Identification of biomarkers associated with extracellular vesicles based on an integrative pan-cancer bioinformatics analysis5
c-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation5
Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial–mesenchymal transition in prostate cancer5
The inhibition effect of natural food supplement active ingredients on TP63 carcinoma cell5
Immunohistochemical evaluation of microsatellite instability in resected colorectal liver metastases: a preliminary experience5
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma5
Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway5
DNA methylation marker to estimate ovarian cancer cell fraction5
Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma5
RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression5
AFP peptide (AFPep) as a potential growth factor for prostate cancer5
Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer5
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro5
Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study5
Prospective evaluation of 68Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prost5
The investigation of the healing effect of active ingredients in traditional medicinal plants on lung cancer5
0.029002904891968